These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2552723)

  • 21. Reduced neutrophil LTB4 release in atopic dermatitis patients despite normal fatty acid composition.
    Schäfer L; Kragballe K; Jepsen LV; Iversen L
    J Invest Dermatol; 1991 Jan; 96(1):16-9. PubMed ID: 1846166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotriene-B4-like immunoreactivity and skin disease.
    Greaves M; Barr R; Camp R
    Lancet; 1984 Jul; 2(8395):160. PubMed ID: 6146055
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum metabolomics study and eicosanoid analysis of childhood atopic dermatitis based on liquid chromatography-mass spectrometry.
    Huang Y; Chen G; Liu X; Shao Y; Gao P; Xin C; Cui Z; Zhao X; Xu G
    J Proteome Res; 2014 Dec; 13(12):5715-23. PubMed ID: 25316199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotrienes.
    Hammarström S
    Annu Rev Biochem; 1983; 52():355-77. PubMed ID: 6311078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Leukotrienes and other products of lipoxygenases. Nature and biological profile].
    Gimeno AL
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):67-92. PubMed ID: 2998154
    [No Abstract]   [Full Text] [Related]  

  • 26. Eicosanoids in inflammation.
    Higgs GA; Moncada S; Vane JR
    Ann Clin Res; 1984; 16(5-6):287-99. PubMed ID: 6100035
    [No Abstract]   [Full Text] [Related]  

  • 27. [Metabolism of arachidonic acid of the skin and its significance in the pathophysiology of inflammatory dermatosis].
    Ruzicka T
    Hautarzt; 1984 Jul; 35(7):337-43. PubMed ID: 6432739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma and skin concentrations of polyunsaturated fatty acids before and after supplementation with n-3 fatty acids in dogs with atopic dermatitis.
    Mueller RS; Fettman MJ; Richardson K; Hansen RA; Miller A; Magowitz J; Ogilvie GK
    Am J Vet Res; 2005 May; 66(5):868-73. PubMed ID: 15934614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
    Brain S; Camp R; Dowd P; Black AK; Greaves M
    J Invest Dermatol; 1984 Jul; 83(1):70-3. PubMed ID: 6330213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and interference of serum and skin lesion levels of leukotrienes in patients with eczema.
    Hua Z; Fei H; Mingming X
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jul; 75(1):51-5. PubMed ID: 16757158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human endothelial cells stimulate leukotriene synthesis and convert granulocyte released leukotriene A4 into leukotrienes B4, C4, D4 and E4.
    Claesson HE; Haeggström J
    Eur J Biochem; 1988 Apr; 173(1):93-100. PubMed ID: 2833396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotriene synthesis by human gastrointestinal tissues.
    Dreyling KW; Hoppe U; Peskar BA; Morgenroth K; Kozuschek W; Peskar BM
    Biochim Biophys Acta; 1986 Sep; 878(2):184-93. PubMed ID: 3019409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacophysiology of atopic dermatitis.
    Hanifin JM
    Clin Rev Allergy; 1986 Feb; 4(1):43-65. PubMed ID: 3008974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid mediators in the rat retina: light exposure and trauma elicit leukotriene B4 release in vitro.
    Reinboth JJ; Gautschi K; Clausen M; Remé CE
    Curr Eye Res; 1995 Nov; 14(11):1001-8. PubMed ID: 8585927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical mediators in atopic dermatitis: involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis.
    Koro O; Furutani K; Hide M; Yamada S; Yamamoto S
    J Allergy Clin Immunol; 1999 Apr; 103(4):663-70. PubMed ID: 10200017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Essential fatty acids and the skin].
    Berbis P; Hesse S; Privat Y
    Allerg Immunol (Paris); 1990 Jun; 22(6):225-31. PubMed ID: 2143069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I; Tsankov N
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of eicosanoids in the pathogenesis of atopic dermatitis.
    Ikai K; Imamura S
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jun; 48(6):409-16. PubMed ID: 8341717
    [No Abstract]   [Full Text] [Related]  

  • 39. Transcriptomic and lipidomic profiling of eicosanoid/docosanoid signalling in affected and non-affected skin of human atopic dermatitis patients.
    Töröcsik D; Weise C; Gericke J; Szegedi A; Lucas R; Mihaly J; Worm M; Rühl R
    Exp Dermatol; 2019 Feb; 28(2):177-189. PubMed ID: 30575130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of arachidonic acid metabolites in local and systemic inflammatory processes.
    Austen KF
    Drugs; 1987; 33 Suppl 1():10-7. PubMed ID: 3036459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.